We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Study to Identify Genetic Makeup of Autism

By Biotechdaily staff writers
Posted on 16 Jan 2004
A genome-wide discovery effort aimed at identifying the key genetic components of autism and autism spectrum disorders (ASDs) has been announced by deCODE genetics (Reykjavik, Iceland). More...
The study is being funded by a U.S.$2.8 million grant from the Simons Foundation (NY, NY, USA).

Autism and ASDs run in families, but the identification of the specific inherited causes may provide valuable insights into the neurologic dysfunctions they evoke. Knowledge of the biology of these disorders may in turn clarify the role of environmental factors and contribute to the development of new methods of diagnosis and treatment. The deCODE study aims to include several hundred individuals with autism and ASDs and several thousand of their relatives, which will enable researchers to identify key genes linked to these disorders and pinpoint which elements of these complex phenotypes are inherited.

The deCODE study team is working with a number of Icelandic organizations. Questionnaires will be given to family members that are designed to capture subtle behavioral and personality traits that may constitute important components of autism and ASDs. Although the number of people diagnosed with autism and ASDs has risen rapidly in recent years, since so little is known about the causes of these disorders it is unclear whether this is due to better diagnosis or to an actual prevalence of the phenotype.

"Our discoveries and other neurologic and behavioral disorders like schizophrenia, anxiety, and depression demonstrate that our population approach has the power to pull out major genes even in the most complex disorders, the basic biology of which is little understood,” said Kari Stefansson, CEO of deCODE. "I am confident that we will succeed in autism as well, and we and our collaborators are very grateful to the Simons Foundation for their support for this project.”



Related Links:
DeCODE genetics

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.